GUIDA, TERESA
 Distribuzione geografica
Continente #
NA - Nord America 159
EU - Europa 73
AS - Asia 20
AF - Africa 8
Totale 260
Nazione #
US - Stati Uniti d'America 151
IT - Italia 25
UA - Ucraina 20
CN - Cina 14
CA - Canada 8
CI - Costa d'Avorio 8
FI - Finlandia 8
DE - Germania 4
IN - India 4
NL - Olanda 4
GB - Regno Unito 3
SE - Svezia 3
FR - Francia 2
IE - Irlanda 2
JP - Giappone 1
LU - Lussemburgo 1
RO - Romania 1
SG - Singapore 1
Totale 260
Città #
Chandler 30
Jacksonville 20
Millbury 10
Princeton 8
Ashburn 7
Ottawa 6
New York 5
Amsterdam 4
Augusta 4
Beijing 4
Nanchang 4
Napoli 4
Wilmington 4
Woodbridge 4
Boston 3
San Mateo 3
Cantù 2
Des Moines 2
Nanjing 2
Pune 2
Toronto 2
Bacoli 1
Bucharest 1
Caserta 1
Changsha 1
Hebei 1
Herndon 1
Leawood 1
Los Angeles 1
Marano Di Napoli 1
Naples 1
Palma Campania 1
Pozzuoli 1
Sannomaru 1
Shanghai 1
Shenyang 1
Trento 1
Turin 1
Udine 1
Villabate 1
Walnut 1
Yellow Springs 1
Totale 151
Nome #
BAY 43-9006 inhibition of oncogenic RET mutants 49
The kinase inhibitor PP1 blocks tumorigenesis induced by RET oncogenes 43
Therapeutic strategies to target the receptor tyrosine kinase AXL in thyroid cancer 43
NCOA4 inhibits initiation of DNA replication to maintain genome stability 41
ZD6474, an orally available inhibitor of KDR tyrosine kinase activity, efficiently blocks oncogenic RET kinases 32
Genetic Alterations in differentiated thyroid cancer:what can be expected for gene expression profiling of thyroid carcinomas 30
Molecular mechanism of 17-allylamino-17-demethoxygeldanamycin (17-AAG)-induced AXL receptor tyrosine kinase degradation. 22
Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutants. 11
Totale 271
Categoria #
all - tutte 1.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.014


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 12 2 4 0 4 1 1 0 0 6 5 7
2020/202144 0 4 4 4 4 4 4 0 4 0 15 1
2021/202240 1 0 0 1 0 4 0 1 2 3 12 16
2022/202366 8 5 2 4 12 7 0 8 10 4 3 3
2023/202440 1 8 2 7 1 6 4 8 0 2 1 0
Totale 271